Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03349606 · ClinicalTrials.gov registry record · Early Phase 1
Cocaine Use Disorder and Cortical Dopamine
A Early Phase 1 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
NCT03349606 is a Early Phase 1 study that has completed, run by University of Pittsburgh. The registered enrollment target is 30 participants.
The verdict
NCT03349606, a Early Phase 1 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goal of this study is to use \[C-11\]FLB 457 and amphetamine (oral, 0.5 mg/kg) to measure cortical dopamine transmission in cocaine dependent individuals and healthy controls
Interventions
- DRUG d-amphetamine
- RADIATION [C-11]FLB 457
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2010-06-02 |
| Est. Completion | 2020-06-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03349606
The ClinicalTrials.gov registry entry for NCT03349606 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which d-amphetamine is the first listed.
NCT03349606 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03349606 about?
NCT03349606 is a clinical study titled "Cocaine Use Disorder and Cortical Dopamine". The goal of this study is to use \[C-11\]FLB 457 and amphetamine (oral, 0.5 mg/kg) to measure cortical dopamine transmission in cocaine dependent individuals and healthy controls
What is the current status of trial NCT03349606?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2010-06-02. Estimated completion is 2020-06-01.
What interventions are being tested in trial NCT03349606?
The interventions under investigation include: d-amphetamine (DRUG), [C-11]FLB 457 (RADIATION).
Who is sponsoring clinical trial NCT03349606?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.